These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9853602)
41. Isis and antisense face crucial test without Novartis. Dove A Nat Biotechnol; 2000 Jan; 18(1):19. PubMed ID: 10625379 [No Abstract] [Full Text] [Related]
42. Gilead is going strong. Levenson E Fortune; 2009 Mar; 159(6):51-2. PubMed ID: 19351097 [No Abstract] [Full Text] [Related]
43. The genetics of a pharma merger. Sanseau P; Chabot-Fletcher M; Browne MJ Drug Discov Today; 2009 Apr; 14(7-8):334-6. PubMed ID: 19121408 [TBL] [Abstract][Full Text] [Related]
44. Industry, clinical trials, and the cost of cancer drugs: an investor's perspective. Fiorino T J Clin Oncol; 2007 Jul; 25(19):e21-3. PubMed ID: 17602065 [No Abstract] [Full Text] [Related]
45. GlaxoSmithKline, Pfizer to merge HIV drug units in new company. AIDS Read; 2009; 19(6):206. PubMed ID: 19642236 [No Abstract] [Full Text] [Related]
46. A billion dollar punt. Nat Biotechnol; 2006 Dec; 24(12):1453. PubMed ID: 17160025 [TBL] [Abstract][Full Text] [Related]
57. Radical treatments for difficult times. Jack A BMJ; 2009 Jan; 338():a2955. PubMed ID: 19141500 [No Abstract] [Full Text] [Related]
58. Pharma giants swap research programs. Cancer Discov; 2014 Jul; 4(7):OF3. PubMed ID: 25002632 [TBL] [Abstract][Full Text] [Related]
59. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]